IPSEN (EPA:IPN) | Finanzwire

Basculer en Français

9777	Companies
195681	Keywords
126715	Articles
104050	Press releases

Home
Companies
IPSEN

BRIEF

published on 01/21/2026 at 17:50, 9 days 2 hours ago

Arbitration Tribunal Confirms Ipsen's Termination of Galderma Agreement

Arbitration Neuroscience Ipsen Galderma IPN10200
PRESS RELEASE

published on 01/21/2026 at 17:45, 9 days 2 hours ago

Arbitration tribunal upholds Ipsen’s termination of R&D agreement with Galderma
Arbitration tribunal supports Ipsen's termination of R&D agreement with Galderma. ICC Tribunal's decision confirms Ipsen's rights to toxin programs in the aesthetic field

Ipsen Arbitration Tribunal Galderma R&D Agreement ICC Tribunal
BRIEF

published on 01/14/2026 at 07:05, 16 days 13 hours ago

Ipsen Showcases Neurological Advancements at TOXINS 2026

Neurological Conditions Post-stroke Spasticity Dysport® EPITOME Trial TOXINS 2026
BRIEF

published on 01/14/2026 at 07:05, 16 days 13 hours ago

Presentation of Ipsen's advances in neurological diseases at the TOXINS congress

Neurological Diseases Dysport Post-stroke Spasticity TOXINS Congress EPITOME Study
PRESS RELEASE

published on 01/14/2026 at 07:00, 16 days 13 hours ago

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS
Ipsen presents new data at TOXINS 2026 conference on post-stroke spasticity and other neurological conditions, emphasizing care solutions. 14 abstracts showcase Dysport's role

Ipsen Neurological Diseases Dysport Post-stroke Spasticity TOXINS 2026
BRIEF

published on 12/22/2025 at 07:05, 1 month 8 days ago

Ipsen Expands Pipeline with Innovative Antibody-Drug Conjugate

Oncology Ipsen Antibody-drug Conjugate Global Rights SIM0613
PRESS RELEASE

published on 12/22/2025 at 07:00, 1 month 8 days ago

Ipsen expands early development pipeline with Simcere Zaiming’s innovative antibody drug conjugate
Ipsen expands pipeline with Simcere Zaiming's novel antibody drug conjugate SIM0613 targeting LRRC15 protein for enhanced tumor penetration and anti-tumor activity. Phase I expected in H2 2026

Ipsen Antibody Drug Conjugate SIM0613 Simcere Zaiming LRRC15
BRIEF

published on 12/05/2025 at 07:03, 1 month 25 days ago

Transfer of Beech Tree shares to the Alasol Foundation by Ipsen

Share Transfer Ipsen Henri Beaufour Beech Tree Alasol Foundation
PRESS RELEASE

published on 12/05/2025 at 06:58, 1 month 25 days ago

Ipsen provides update on legacy of Henri Beaufour
Ipsen provides update on the transfer of Beech Tree shares to the Alasol Foundation following the passing of Henri Beaufour, Ipsen's Board Member, to support education for disadvantaged children and young adults

Education Ipsen Henri Beaufour Alasol Foundation Beech Tree Shares
BRIEF

published on 12/01/2025 at 07:05, 1 month 29 days ago

Ipsen Announces the Passing of Henri Beaufour

Business Development Board Member Ipsen Henri Beaufour Corporate Legacy

1 2 ... 4

Accesswire

Published on 01/30/2026 at 14:00, 6 hours 22 minutes ago

CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 11 hours 47 minutes ago

Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 12 hours 22 minutes ago

Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 18 hours 7 minutes ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 20 hours 22 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies

View all ACCESSWIRE

EQS Group

Published on 01/30/2026 at 20:10, 12 minutes ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 20:09, 12 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 20:07, 15 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 19:13, 1 hour 9 minutes ago

Total Voting Rights
Published on 01/30/2026 at 18:31, 1 hour 50 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 01/30/2026 at 17:45, 2 hours 37 minutes ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 08:00, 12 hours 22 minutes ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 1 day 2 hours ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 1 day 2 hours ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 1 day 2 hours ago

Cegedim generated LFL revenue growth of 1.1% in 2025

View all LES ECHOS COMFI WIRE